COVID-19有创机械通气患者病死率:一项Meta分析
该Meta分析纳入69项研究、57,420例接受有创机械通气的成人COVID-19患者,报告病死率为45%(95%CI 39-52%)。年龄分层分析显示≤40岁者合并病死率47.9%(95%CI 46.4-49.4%),>80岁者84.4%(95%CI 83.3-85.4%),早期疫情中心病死率更高,研究间异质性高(I2>90%)。
要点
- 接受IMV的COVID-19成人患者报告病死率约45%。
- 年龄>80岁患者合并病死率84.4%,显著高于≤40岁者的47.9%。
- 仅22.8%的IMV患者有明确出院结局,CFR报告方法异质。
核心结论
- 基于报告CFR,近半数接受IMV的COVID-19患者死亡。
- CFR报告方法不一导致研究间CFR范围较宽。
- 老年患者和早期疫情中心报告CFR更高,可能受ICU资源有限影响。
- 对所有患者报告明确结局有助于研究间比较。
研究设计与样本
- 系统检索PubMed、Embase、medRxiv、bioRxiv、COVID-19 living systematic review及国家登记数据库。
- 纳入69项研究,描述57,420例接受IMV的成人COVID-19患者。
- 主要结局为确诊COVID-19需IMV患者的报告CFR,并分析出院时明确医院CFR。
- 按年龄、地理区域及基于纽卡斯尔-渥太华量表的研究质量分析CFR。
- 系统评价注册于PROSPERO(CRD42020186997)。
主要发现
- 总体报告CFR估计为45%(95%CI 39-52%)。
- 年龄分层合并CFR从≤40岁者的47.9%(95%CI 46.4-49.4%)至>80岁者的84.4%(95%CI 83.3-85.4%)。
- CFR在早期COVID-19疫情中心更高。
- 总体异质性高(I2>90%),Egger回归检验无显著发表偏倚。
关键数值与推荐
- 报告CFR总体为45%(95%CI 39-52%)。
- ≤40岁患者合并CFR为47.9%(95%CI 46.4-49.4%)。
- >80岁患者合并CFR为84.4%(95%CI 83.3-85.4%)。
- 明确医院结局仅覆盖13,120例(22.8%)IMV患者。
临床怎么用
- 向老年COVID-19患者及家属交代有创机械通气预后时,可参考年龄分层CFR。
- 解读CFR研究时应关注结局报告方法差异及明确结局患者比例。
- 比较不同中心或时期CFR时需考虑ICU资源及疫情阶段影响。
局限性
- 研究间异质性高(I2>90%)。
- 仅22.8%的IMV患者有明确医院结局。
- CFR报告方法不一导致研究间CFR范围较宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Initial reports of case fatality rates (CFRs) among adults with coronavirus disease (COVID-19) receiving invasive mechanical ventilation (IMV) are highly variable.Objectives: To examine the CFR of patients with COVID-19 receiving IMV.Methods: Two authors independently searched PubMed, Embase, medRxiv, bioRxiv, the COVID-19 living systematic review, and national registry databases. The primary outcome was the "reported CFR" for patients with confirmed COVID-19 requiring IMV. "Definitive hospital CFR" for patients with outcomes at hospital discharge was also investigated. Finally, CFR was analyzed by patient age, geographic region, and study quality on the basis of the Newcastle-Ottawa Scale.Measurements and Results: Sixty-nine studies were included, describing 57,420 adult patients with COVID-19 who received IMV. Overall reported CFR was estimated as 45% (95% confidence interval [CI], 39-52%). Fifty-four of 69 studies stated whether hospital outcomes were available but provided a definitive hospital outcome on only 13,120 (22.8%) of the total IMV patient population. Among studies in which age-stratified CFR was available, pooled CFR estimates ranged from 47.9% (95% CI, 46.4-49.4%) in younger patients (age ≤40 yr) to 84.4% (95% CI, 83.3-85.4%) in older patients (age >80 yr). CFR was also higher in early COVID-19 epicenters. Overall heterogeneity is high (I2 >90%), with nonsignificant Egger's regression test suggesting no publication bias.Conclusions: Almost half of patients with COVID-19 receiving IMV died based on the reported CFR, but variable CFR reporting methods resulted in a wide range of CFRs between studies. The reported CFR was higher in older patients and in early pandemic epicenters, which may be influenced by limited ICU resources. Reporting of definitive outcomes on all patients would facilitate comparisons between studies.Systematic review registered with PROSPERO (CRD42020186997).
引用
- Lim ZJ, Subramaniam A, Ponnapa Reddy M, et al. Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis. Am J Respir Crit Care Med. 2021. PMID: 33119402. doi:10.1164/rccm.202006-2405OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。